Kellen Voss, PhD

Book a Call: https://calendar.app.google/Cbk9G9WDsiQjVb9b9 VHS is focused on Healthcare and Pharmaceutical risk mitigation, strategic acceleration, team building, and operational excellence. Entrepreneur Advocacy Partner Due diligence

Part Owner Regional Director, Midwest Responsible for the business expansion of Samsaric Brewing Company into Chicago

Built and led a global field medical team to accelerate Phase III trial success and develop scalable strategies for rare neurology assets. +Recruited and managed 13 Associate Directors across US, Australia, and Europe, reducing site activation timelines and accelerating recruitment goals +Designed and implemented global medical strategy for rare epilepsy asset, aligning with clinical development and launch objectives across 3 regions +Established CRM infrastructure and compliant workflows, improving the insight capture rate and cross-functional visibility +Forged relationships with 50+ KOLs and patient advocacy groups, driving community engagement ahead of launch +Represented Lundbeck at global congresses, advocacy meetings and advisory boards, elevating presence and securing strategic partnerships +Synthesized field insights into actionable strategy documents, directly informing protocol amendments and patient-centric trial design +Enabled rapid deployment of medical education initiatives, contributing to a 25% increase in investigator engagement across trial sites

Acquired by Lundbeck in 2024. Integrated in Feb 2025. Built and led a global field medical team to accelerate Phase III trial success and develop scalable strategies for rare neurology assets. +Recruited and managed 13 Associate Directors across US, Australia, and Europe, reducing site activation timelines and accelerating recruitment goals +Designed and implemented global medical strategy for rare epilepsy asset, aligning with clinical development and launch objectives across 3 regions +Established CRM infrastructure and compliant workflows, improving the insight capture rate and cross-functional visibility +Forged relationships with 50+ KOLs and patient advocacy groups, driving community engagement ahead of launch +Represented Longboard at global congresses, advocacy meetings and advisory boards, elevating presence and securing strategic partnerships +Synthesized field insights into actionable strategy documents, directly informing protocol amendments and patient-centric trial design +Enabled rapid deployment of medical education initiatives, contributing to a 25% increase in investigator engagement across trial sites

Directed Phase III buildout and launch strategy for a Parkinson’s drug/device, while scaling infrastructure and global medical impact. +Built and scaled medical infrastructure (Veeva/Salesforce) supporting 2 pipeline assets (rare disease), reducing operational overhead by 40% +Led 3 advisory boards and developed launch strategy that accelerated time-to-submission by 3 months for lead Parkinson’s asset +Co-authored and reviewed FDA submission documentation +Integrated new technologies for insight capture and KOL mapping, increasing field team productivity by 50% +Served as promotional and non-promotional medical reviewer, ensuring compliance and reducing review cycle time by 25% +Led field strategy across US and Europe, aligning tactics and developing KPIs +Selected for corporate strategy rotation; built TPPs and value propositions that shaped 2-year asset planning roadmap +Managed and developed 2 field employees, improving performance metrics by 40% and retention

• Served as an Assistant Field Manager since 2020, showcasing leadership in personnel management, hiring, mentoring, and coaching. • Implemented quality improvement projects for data optimization with Salesforce, Microsoft Teams, Veeva, PharmaSpectra (KOLs), Acceleration Point (DOLs), and BOAST (congresses).

Served as field lead for Parkinson’s and epilepsy portfolio, driving advocacy, access, and strategic communication. +Managed field strategy for 4 key products, contributing to increased formulary wins and improved patient access +Built relationships with 100+ stakeholders including KOLs, payers, and advocacy groups, enhancing brand trust and reach +Partnered with government affairs to influence Medicaid policy, resulting in expanded access to seizure medications in 2 states +Achieved President’s Club twice for excellence in medical affairs and stakeholder engagement +Trained 20+ promotional speakers for product launch, improving speaker ratings and HCP satisfaction scores +Completed marketing rotation focused on hospital care; developed patient journey maps and strategic engagement plans used in regional campaigns

Position Summary: The CAC is a partner to the clinical customer through adoption and use of Life Technologies product portfolio. Responsible for the provision of scientific application support and training on Life Technologies applications being utilized in both CLIA and GLP labs, thereby contributing substantially to customer satisfaction. Support sales in the achievement of the order plan, by strategic planning and delivery of product line- specific customer support activities. The CAC is responsible for keeping up to date with product and state of the art scientific knowledge.

I was a Postdoctoral Trainee on a NIA T32 grant focused on the neurobiology of aging and translational research, managed by Dr. Henryk Urbanski. My mentor was Dr. Joseph Quinn. The research focused on elucidating the role of transition metals in the progression of neurodegenerative tauopathies. Also, I developed assays to screen for inhibitors of tau aggregation and phosphorylation. Finally, I was certified in Human Investigations in order to successfully design, implement and analyze clinical trials. I successfully obtained a pilot grant from the Oregon Alzheimer's Disease Center to develop an accelerated aging mouse model that develops tauopathies in the absence of any genetic mutations. This work provided me with project management, personnel management, grant writing, budgeting, publication writing and presentation skills. I also was able to build and maintain KOL relationships and expand my medical knowledge.

This certification provides formal training for successful understanding of all aspects of clinical trial work including clinical trial design and analysis.